 DUBLIN, Ireland and TREVOSE, Pa., March 15, 2021 GLOBE NEWSWIRE -- Strongbridge Biopharma plc Nasdaq: SBBP, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that management will present at Oppenheimers 31st Annual Healthcare Conference on Wednesday, March 17, at 10:00 a.m. ET. The conference is being held virtually. 